Novo’s broad Flagship partnership starts with obesity at Omega and MASH at Cellarity
Novo Nordisk and Flagship Pioneering unveiled the first two research tie-ups involved in their sprawling cardiometabolic partnership on Thursday morning.
The pair is employing Omega …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.